U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Advisory Committee on Immunization Practices (ACIP)

CDC Stacks Public Health Publications

The ACIP is a group of medical and public health experts that develops recommendations on the use of vaccines in the civilian population of the United States. The ACIP holds three meetings each year at the Centers for Disease Control and Prevention (CDC), in Atlanta, Georgia to make vaccine recommendations. Meetings are open to the public and available online via webcast. More information on ACIP is available at: https://www.cdc.gov/vaccines/acip/index.html.

(93)
(134)
(234)
(272)
(175)
(108)
(133)
(111)
(96)
(79)
(115)
(115)
(125)
(16)
(23)
(16)
(18)
(13)
(17)
(9)
(8)
(15)
(11)
(6)
(10)
(10)
(5)
(10)
(11)
(5)
(8)
(9)
(6)
(9)
(8)
(7)
(6)
(10)
(5)
(6)
(5)
(6)
(6)
(5)
(5)
(6)
(9)
(3)
(8)
(4)
(3)
(2)
(5)
(3)
(2)
(4)
(3)
(3)
(2)
(2)
(1)
0 of 61
(12)
(32)
(108)
(35)
(11)
(1)
(1)
(48)
(48)
(49)
(7)
(1293)
(463)
(7)
0 of 14
(1)
(1)
(1)
(4)
(2)
(1)
(1)
(2)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(6)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(406)
(1)
(1)
(1)
(1)
(1)
(1)
0 of 46
(1)
(1)
(1)
0 of 3
(10)
(5)
(1)
(4)
(2)
(3)
(1)
(5)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(126)
(1)
(146)
(1)
(33)
(66)
(1)
(1)
(62)
(14)
(2)
(3)
(18)
(1)
(4)
(1)
(1)
(1)
(2)
(31)
(2)
(3)
(1)
(1)
(3)
(6)
(1)
(1)
(10)
(1)
(3)
(2)
(2)
(14)
(2)
(2)
(3)
(5)
(2)
(1)
(9)
(3)
(1)
(2)
(2)
(4)
(1)
(1)
(1)
(1)
(5)
(3)
(1)
(7)
(1)
(10)
(1)
(1)
(10)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(9)
(1)
(1)
(1)
(12)
(1)
(2)
(1)
(3)
(9)
(1)
(6)
(1)
(3)
(10)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(3)
(1)
(11)
(2)
(2)
(4)
(1)
(3)
(13)
(8)
(153)
(106)
(2)
(2)
(1)
(1)
(11)
(2)
(1)
(10)
(2)
(7)
(2)
(1)
(1)
(1)
(7)
(15)
(4)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(20)
(5)
(197)
(44)
(5)
(4)
(1)
(19)
(2)
(2)
(82)
(2)
(257)
(6)
(21)
(2)
(1)
(3)
(1)
(1)
(8)
(1)
(4)
(2)
(1)
(1)
(117)
(7)
(5)
(3)
(1)
(1)
(1)
(3)
(1)
(1)
(3)
(35)
(2)
(1)
(16)
(2)
(12)
(1)
(32)
(2)
(2)
(1)
(1)
(1)
(3)
(22)
(1)
(2)
(2)
(10)
(2)
(2)
(2)
(3)
(1)
(1)
(2)
(23)
(10)
(3)
(5)
(1)
(1)
(15)
(1)
(3)
(1)
(9)
(1)
(2)
(2)
(1)
(1)
(2)
(2)
(1)
(4)
(1)
(1)
(17)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(3)
(2)
(1)
(2)
(1)
(5)
(1)
(1)
(2)
(2)
(1)
(4)
(1)
(9)
(2)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(51)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(21)
(3)
(1)
(5)
(1)
(15)
(1)
(56)
(1)
(2)
(5)
(2)
(2)
(1)
(1)
(3)
(5)
(2)
(1)
(15)
(1)
(1)
(2)
(2)
(1)
(3)
(1)
(33)
(2)
(1)
(3)
(2)
(2)
(1)
(19)
(2)
(2)
(4)
(4)
(2)
(1)
(1)
(2)
(5)
(5)
(1)
(1)
(1)
(7)
(9)
(9)
(1)
(1)
(3)
(1)
(26)
(3)
(1)
(2)
(1)
(1)
(10)
(1)
(2)
(1)
(1)
(39)
(2)
(1)
(1)
(1)
(3)
(4)
(1)
(2)
(3)
(1)
(35)
(1)
(1)
(1)
(7)
(1)
(6)
(2)
(10)
(11)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(165)
(5)
(1)
(1)
(4)
(343)
(1)
(6)
(3)
(76)
(2)
(2)
(1)
(1)
(1)
(2)
(50)
(6)
(4)
(321)
(1)
(1)
(1)
(192)
(1)
(2)
(17)
(3)
(2)
(3)
(3)
(1)
(1)
(1)
(1)
(6)
(6)
(104)
(1)
(69)
(1)
(5)
(2)
(3)
(2)
(1)
(1)
(39)
(1)
(1)
(10)
(1)
(11)
(4)
(25)
(15)
(2)
(1)
(2)
(1)
(3)
(10)
(4)
(15)
(2)
(13)
(2)
(18)
(6)
(2)
(1)
(1)
(2)
(2)
(4)
(172)
(18)
(2)
(1)
(11)
(5)
(2)
(2)
(2)
(1)
(1)
(1)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(1)
(1)
(1)
(1)
(12)
(3)
(2)
(4)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(10)
(1)
(4)
(1)
(1)
(31)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(3)
(2)
(6)
(1)
(13)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(40)
(1)
(2)
(8)
(1)
(11)
(1)
(1)
(6)
(28)
(1)
(1)
(1)
(2)
(1)
(7)
(1)
(9)
(1)
(1)
(1)
(2)
(1)
(2)
(4)
(1)
(1)
(3)
(14)
(3)
(1)
(10)
(2)
(1)
(104)
(1)
(1)
(1)
(1)
(1)
(1)
(61)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(10)
(1)
(3)
(4)
(14)
(1)
(12)
(3)
(4)
(3)
(1)
(6)
(1)
(7)
(1)
(1)
(5)
(1)
(13)
(2)
(1)
(1)
(1)
(1)
(1)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(4)
(1)
(7)
(1)
(3)
(6)
(2)
(1)
(2)
(1)
(2)
(1)
(7)
(1)
(1)
(1)
(2)
(1)
(1)
(29)
(152)
(5)
(1)
(1)
(1)
(3)
(2)
(55)
(1)
(1)
(34)
(1)
(8)
(1)
(1)
(56)
(2)
(1)
(6)
(1)
(1)
(1)
(35)
(2)
(1)
(2)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(17)
(1)
(1)
(8)
(1)
(91)
(3)
(1)
(2)
(4)
(1)
(1)
(11)
(2)
(3)
(1)
(3)
(1)
(4)
(2)
(6)
(2)
(2)
(1)
(8)
(2)
(1)
(5)
(1)
(10)
(12)
(1)
(6)
(1)
(1)
(1)
(6)
(1)
(35)
(1)
(9)
(1)
(62)
(6)
(3)
(2)
(1)
(1)
(1)
(2)
(1)
(26)
(1)
(1)
(1)
(1)
(1)
(3)
(3)
(1)
(16)
(1)
(1)
(1)
(4)
(2)
(14)
(1)
(1)
(4)
(3)
(2)
(12)
(1)
(1)
(4)
(5)
(2)
(1)
(11)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(10)
(6)
(2)
(1)
(49)
(13)
(8)
(48)
(8)
(2)
(13)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(4)
(18)
(12)
(1)
(1)
(3)
(9)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(32)
(5)
(2)
(13)
(5)
(1)
(1)
(2)
(19)
(1)
(6)
(2)
(1)
(2)
(1)
(2)
(2)
(1)
(1)
(3)
(2)
(1)
(4)
(2)
(1)
(1)
(2)
(1)
(1)
(26)
(2)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(11)
(1)
(2)
(1)
(2)
(1)
(3)
(2)
(6)
(1)
(5)
(4)
(8)
(5)
(1)
(1)
(21)
(1)
(1)
(2)
(7)
(3)
(2)
(2)
(2)
(1)
(2)
(1)
(1)
(630)
(17)
(2)
(1)
(1)
(5)
(1)
(1)
(24)
(22)
(4)
(4)
(1)
(13)
(379)
(1)
(28)
(23)
(23)
(1)
(1)
(1)
(21)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(2)
(1)
(1)
(51)
(2)
(1)
(11)
(1)
(1)
(18)
(1)
(2)
(1)
(2)
(5)
(3)
(1)
(1)
(12)
(1)
(2)
(170)
(2)
(1)
(1)
(1)
(1)
(21)
(1)
(1)
(10)
(1)
(1)
(4)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(2)
(1)
(11)
(2)
(1)
(2)
(1)
(2)
(1)
(2)
(1)
(33)
(1)
(2)
(4)
0 of 940
(1)
(1)
(1)
(3)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(7)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(39)
(2)
(1)
(8)
(16)
(1)
(4)
(4)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(4)
(2)
(1)
(1)
(3)
(23)
(1)
(1)
(8)
(2)
(1)
(11)
(1)
(1)
(1)
(15)
(1)
(1)
(14)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(3)
(8)
(21)
(1)
(1)
(9)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(16)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(10)
(1)
(1)
(2)
(7)
(1)
(1)
(5)
(1)
(8)
(2)
(5)
(10)
(2)
(1)
(1)
(2)
(2)
(2)
(22)
(3)
(4)
(4)
(4)
(3)
(1)
(22)
(1)
(7)
(1)
(4)
(2)
(2)
(4)
(4)
(2)
(32)
(2)
(1)
(1)
(1)
(6)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(31)
(3)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(7)
(1)
(4)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(4)
(2)
(2)
(3)
(1)
(7)
(1)
(2)
(1)
(1)
(10)
(10)
(1)
(11)
(2)
(6)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(9)
(4)
(2)
(1)
(1)
(1)
(5)
(8)
(1)
(2)
(1)
(5)
(7)
(1)
(1)
(1)
(3)
(2)
(2)
(1)
(12)
(1)
(2)
(5)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(51)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(4)
(2)
(1)
(15)
(1)
(4)
(8)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(7)
(1)
(3)
(3)
(1)
(4)
(4)
(1)
(1)
(3)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(14)
(20)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(2)
(12)
(1)
(1)
(1)
(1)
(9)
(1)
(8)
(1)
(1)
(1)
(1)
(1)
(2)
(8)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(7)
(1)
(11)
(1)
(2)
(2)
(1)
(1)
(1)
(13)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(7)
(2)
(1)
(1)
(1)
(4)
(3)
(1)
(1)
(1)
(1)
(11)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(7)
(21)
(1)
(2)
(1)
(3)
(7)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(15)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(34)
(2)
(1)
(2)
(8)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(15)
(1)
(1)
(1)
(5)
(1)
(13)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(7)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(14)
(9)
(1)
(1)
(1)
(2)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(3)
(11)
(1)
(37)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(8)
(1)
(1)
(1)
(4)
(2)
(10)
(1)
(8)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(5)
(3)
(2)
(2)
(1)
(1)
(4)
(6)
(8)
(1)
(6)
(1)
(2)
(1)
(3)
(5)
(2)
(4)
(2)
(5)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(5)
(1)
(11)
(2)
(1)
(3)
(1)
(4)
(2)
(1)
(12)
(2)
(2)
(6)
(1)
(1)
(9)
(2)
(1)
(2)
(1)
(7)
(7)
(1)
(1)
(2)
(1)
(11)
(8)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(3)
(54)
(2)
(4)
(4)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(6)
(9)
(3)
(1)
(1)
(1)
(1)
(2)
(2)
(3)
(1)
(1)
(4)
(1)
(3)
(1)
(1)
(6)
(3)
(2)
(2)
(1)
(1)
(1)
(4)
(7)
(2)
(4)
(1)
(8)
(1)
(1)
(25)
(1)
(1)
(10)
(17)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(6)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(14)
(4)
(3)
(2)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(18)
(1)
(2)
(1)
(1)
(7)
(1)
(2)
(10)
(1)
(1)
(1)
(1)
(30)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(3)
(2)
(1)
(3)
(1)
(2)
(1)
(19)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(8)
(1)
(30)
(5)
(1)
(11)
(3)
(1)
(1)
(2)
(1)
(2)
(2)
(8)
(1)
(1)
(1)
(1)
(1)
(7)
(4)
(2)
(1)
(4)
(2)
(1)
(2)
(1)
(4)
(1)
(1)
(1)
(1)
(2)
(1)
(8)
(2)
(1)
(1)
(2)
(45)
(1)
(1)
(7)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(10)
(1)
(1)
(1)
(10)
(1)
(1)
(13)
(1)
(8)
(7)
(1)
(2)
(1)
(8)
(8)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(7)
(8)
(2)
(1)
(32)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(10)
(1)
(1)
(1)
(2)
(1)
(3)
(5)
(4)
(1)
(2)
(2)
(1)
(1)
(9)
(2)
(2)
(10)
(1)
(1)
(1)
(2)
(1)
(5)
(1)
(1)
(4)
(2)
(2)
(26)
(1)
(1)
(24)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(4)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(5)
(4)
(2)
(2)
(1)
(1)
(11)
(3)
(1)
(4)
(1)
(1)
(5)
(1)
(2)
(9)
(1)
(1)
(6)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
0 of 899
(2)
(1)
(1)
(3)
(1)
(1)
(2)
(2)
(5)
(24)
(3)
(4)
(6)
(1)
(16)
(21)
(9)
(1)
(1)
(1)
(1)
(6)
(3)
(1)
(4)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(8)
(1)
(3)
(6)
(1)
(1)
(2)
(14)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(29)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(50)
(113)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(2)
(2)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(2)
(4)
(1)
(1)
(1)
(5)
(1)
(11)
(1)
(2)
(1)
(1)
(4)
(2)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(1)
(1)
(6)
(1)
(1)
(8)
(1)
(2)
(7)
(5)
(1)
(1)
(5)
(2)
(6)
(1)
(1)
(1)
(12)
(1)
(9)
(2)
(1)
(5)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(4)
(3)
(4)
(1)
(16)
(11)
(1)
(8)
(6)
(1)
(3)
(1)
(5)
(1)
(3)
(25)
(3)
(8)
(1)
(1)
(1)
(30)
(4)
(6)
(1)
(12)
(34)
(30)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(9)
(1)
(10)
(14)
(2)
(10)
(1)
(90)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(46)
(4)
(3)
(2)
(66)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(83)
(1)
(1)
(1)
(2)
(53)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(3)
(2)
(6)
(9)
(1)
(10)
(1)
(1)
(2)
(3)
(6)
(2)
(1)
(5)
(4)
(1)
(3)
(2)
(1)
(1)
(13)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(10)
(1)
(22)
(3)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(4)
(1)
(1)
(1)
(4)
(9)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(2)
(3)
(3)
(1)
(2)
(10)
(1)
(6)
(1)
(1)
(11)
(1)
(1)
(1)
(1)
(3)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(13)
(1)
(14)
(547)
(1)
(1)
(1)
(6)
(1)
(3)
(1)
(4)
(10)
(1)
(15)
(11)
(14)
(1)
(4)
(4)
(1)
(2)
(2)
(5)
(1)
(4)
(1)
(162)
(1)
(5)
(1)
(3)
(7)
(3)
(1)
(33)
(2)
(14)
(3)
(3)
(9)
(2)
(1)
(10)
(1)
(2)
(30)
(6)
(1)
(4)
(4)
(5)
(2)
(7)
(1)
(6)
(2)
(1)
(19)
(15)
(1)
(1)
(9)
(5)
(1)
(2)
(2)
(18)
(3)
(5)
(46)
(2)
(1)
(2)
(3)
(2)
(1)
(3)
(4)
(1)
(5)
(1)
(1)
(4)
(3)
(1)
(1)
(7)
(2)
(2)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(3)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(10)
(3)
(2)
(3)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(11)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
0 of 464
(1)
(74)
(1)
(1)
(1624)
(32)
(7)
(8)
(1)
(14)
(102)
(200)
(10)
(12)
(32)
(1295)
(1)
(18)
(2)
(2)
(38)
(1)
(1)
(1)
0 of 24
(1)
(1)
(1)
(1)
(1)
(1)
0 of 6
(1)
0 of 1
Showing 1421 - 1440 of 2154 results
  • Summary of clinical trial data and GRADE for 9valent HPV vaccine
    Summary of clinical trial data and GRADE for 9-valent HPV vaccine
    Petrosky, Emiko
    February 26, 2015 | ACIP: Human Papillomavirus (HPV)
    No Description
    Public Domain
  • Advisory Committee on Immunization Practices ACIP February26 2015 welcome introductions
    Advisory Committee on Immunization Practices (ACIP), February26, 2015 : welcome & introductions
    United States. Advisory Committee on Immunization Practices. Meeting 2015 February 26 : Atlanta, GA)
    February 26, 2015 | ACIP: Meeting Agenda, Minutes, etc.
    No Description
    Public Domain
  • ACIP Japanese Encephalitis JE and Yellow Fever YF Vaccines Work Group
    ACIP Japanese Encephalitis (JE) and Yellow Fever (YF) Vaccines Work Group
    Bocchini, Joseph A.
    February 26, 2015 | ACIP: Japanese Encephalitis
    No Description
    Public Domain
  • Human papillomavirus HPV vaccine session
    Human papillomavirus (HPV) vaccine session
    Bocchini, Joseph A.
    February 26, 2015 | ACIP: Human Papillomavirus (HPV)
    No Description
    Public Domain
  • Overview of costeffectiveness of 9valent HPV vaccination
    Overview of cost-effectiveness of 9-valent HPV vaccination
    Chesson, Harrell W.
    February 26, 2015 | ACIP: Human Papillomavirus (HPV)
    No Description
    Public Domain
  • Summary of GRADE consideration for special populations and proposed recommendations for YF vaccine booster doses
    Summary of GRADE, consideration for special populations, and proposed recommendations for YF vaccine booster doses
    Staples, J. Erin
    February 26, 2015 | ACIP: Japanese Encephalitis
    No Description
    Public Domain
  • Proposed HPV vaccination recommendations
    Proposed HPV vaccination recommendations
    Markowitz, Lauri E.
    February 26, 2015 | ACIP: Human Papillomavirus (HPV)
    No Description
    Public Domain
  • Use of 9Valent Human Papillomavirus HPV Vaccine Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices
    Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices
    Petrosky, Emiko ;
    Bocchini, Joseph A.
    Mar 27 2015 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    During its February 2015 meeting, the Advisory Committee on Immunization Practices (ACIP) recommended 9-valent human papillomavirus (HPV) vaccine (9vHPV) (Gardasil 9, Merck and Co., Inc.) as one of three HPV vaccines that can be used for routine vaccination. HPV vaccine is recommended for routine vaccination at age 11 or 12 years. ACIP also recomme ...
    Supporting Files Public Domain
  • Supplemental Information and Guidance for Vaccination Providers Regarding Use of 9Valent HPV
    Supplemental Information and Guidance for Vaccination Providers Regarding Use of 9-Valent HPV
    Petrosky, Emiko ;
    Bocchini, Joseph A.
    Mar 27 2015 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    A 9-valent human papillomavirus (HPV) vaccine (9vHPV, Gardasil 9, Merck & Co.) was licensed for use in females and males in December 2014. The 9vHPV was the third HPV vaccine licensed in the United States by the Food and Drug Administration (FDA); the other vaccines are bivalent HPV vaccine (2vHPV, Cervarix, GlaxoSmithKline), licensed for use in fe ...
    Public Domain
  • Updated Recommendations for the Use of Typhoid Vaccine Advisory Committee on Immunization Practices United States 2015
    Updated Recommendations for the Use of Typhoid Vaccine — Advisory Committee on Immunization Practices, United States, 2015
    Jackson, Brendan R. ;
    Iqbal, Shahed
    Mar 27 2015 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    These revised recommendations of the Advisory Committee on Immunization Practices update recommendations published in MMWR in 1994 and include updated information on the two currently available vaccines and on vaccine safety. They also include an update on the epidemiology of enteric fever in the United States, focusing on increasing drug resistanc ...
    Supporting Files Public Domain
  • Early release of selected estimates based on data from the JanuarySeptember 2014 National Health Interview Survey
    Early release of selected estimates based on data from the January–September 2014 National Health Interview Survey
    3/15 | National Health Interview Survey Early Release Program
    In this release, the Centers for Disease Control and Prevention’s (CDC) National Center for Health Statistics (NCHS) updates estimates for 15 selected health measures based on data from the January–September 2014 National Health Interview Survey (NHIS) and presents estimates from 1997 through 2013 for comparison. The 15 Early Release measures are b ...
    Public Domain
  • Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older United States 2015
    Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2015
    Kim, David K. ;
    Bridges, Carolyn B.
    Feb 06 2015 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    In October 2014, the Advisory Committee on Immunization Practices (ACIP) approved the Recommended Immunization Schedule for Adults Aged 19 Years or Older, United States, 2015. This schedule provides a summary of ACIP recommendations for the use of vaccines routinely recommended for adults aged 19 years or older in two figures, footnotes for each va ...
    Supporting Files Public Domain
  • Advisory Committee on Immunization Practices recommended immunization schedules for persons aged 0 through 18 years United States 2015
    Advisory Committee on Immunization Practices recommended immunization schedules for persons aged 0 through 18 years — United States, 2015
    Strikas, Raymond A.
    Feb 06 2015 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Each year, the Advisory Committee on Immunization Practices (ACIP) reviews the recommended immunization schedules for persons aged 0 through 18 years to ensure that the schedules reflect current recommendations for Food and Drug Administration-licensed vaccines. In October 2014, ACIP approved the recommended immunization schedules for persons aged ...
    Supporting Files Public Domain
  • Recommended adult immunization schedule United States 2015
    Recommended adult immunization schedule -- United States, 2015
    United States. Advisory Committee on Immunization Practices.  ...
    02/04/2015
    The 2015 Adult Immunization Schedule was approved by the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP), American Academy of Family Physicians (AAFP), the American College of Physicians (ACP), the American College of Obstetricians and Gynecologists (ACOG), and the American College of Nurse-Mid ...
    Superseded Public Domain
  • Recommended immunization schedules for persons aged 0 through 18 years United States 2015
    Recommended immunization schedules for persons aged 0 through 18 years -- United States, 2015
    United States. Advisory Committee on Immunization Practices.  ...
    02/02/2015
    This schedule includes recommendations in effect as of January 1, 2015. Any dose not administered at the recommended age should be administered at a subsequent visit, when indicated and feasible. The use of a combination vaccine generally is preferred over separate injections of its equivalent component vaccines. Vaccination providers should consul ...
    Superseded Public Domain
  • Advisory Committee on Immunization Practices ACIP summary report June 2526 2014 Atlanta Georgia
    Advisory Committee on Immunization Practices (ACIP) summary report : June 25-26, 2014, Atlanta, Georgia
    United States. Advisory Committee on Immunization Practices.
    11/07/2014 | ACIP: Meeting Agenda, Minutes, etc.
    No Description
    Public Domain
  • Overview of serogroup B meningococcal vaccines and considerations for use
    Overview of serogroup B meningococcal vaccines and considerations for use
    Patel, Manisha
    October 30, 2014 | ACIP: Menigococcal
    No Description
    Public Domain
  • Human papillomavirus HPV vaccine session
    Human papillomavirus (HPV) vaccine session
    Bocchini, Joseph A.
    October 30, 2014 | ACIP: Human Papillomavirus (HPV)
    No Description
    Public Domain
  • Typhoid and typhoid vaccines introduction
    Typhoid and typhoid vaccines : introduction
    Mahon, Barbara E.
    October 30, 2014 | ACIP: Typhoid
    No Description
    Public Domain
  • Typhoid fever and typhoid vaccines
    Typhoid fever and typhoid vaccines
    Jackson, Brendan R.
    October 30, 2014 | ACIP: Typhoid
    No Description
    Public Domain
1421 - 1440 / 2154